Search filters

List of works by Loïc Ysebaert

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

scientific article published on 23 November 2017

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

scientific article published on 14 February 2017

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers

scientific article published on 08 June 2018

Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group

scientific article published on 11 April 2019

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.

scientific article published on 10 March 2017

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia

scientific article published on 18 February 2019

Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).

scientific article

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

scientific article published on 14 August 2019

Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.

scientific article published on 25 April 2017

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients

scientific article published on 28 July 2019

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

scientific article published on 01 September 2018

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

scientific article

Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data

scientific article published on 09 June 2020

Paulina is supported by:

About Paulina

Help